Both executives raise a problem with fixing researchanddevelopment that should scare executives at less productive companies: Sometimes trying to fix things can just make them worse.
Once more: I find it hard to understand how someone who worked as head of ResearchandDevelopment at Pfizer could possibly deny this basic, universally recognised problem of poor external validity in clinical trials.